SenzaGen AB (STO:SENZA)
Sweden · Delayed Price · Currency is SEK 5.50
0.00 (0.00%)
Apr 24, 2026, 4:37 PM CET
SenzaGen AB Market Cap
SenzaGen AB has a market cap or net worth of 178.79 million as of April 24, 2026. Its market cap has increased by 36.49% in one year.
Market Cap
178.79M
Enterprise Value
170.88M
Revenue
57.97M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.50
Market Cap Chart
Since September 21, 2017, SenzaGen AB's market cap has decreased from 669.46M to 178.79M, a decrease of -73.29%. That is a compound annual growth rate of -14.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 178.79M | -0.33% |
| Dec 30, 2025 | 179.38M | -11.88% |
| Dec 30, 2024 | 203.58M | 15.61% |
| Dec 29, 2023 | 176.09M | -39.28% |
| Dec 30, 2022 | 289.98M | 22.62% |
| Dec 30, 2021 | 236.48M | -15.48% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 138.47B |
| Getinge AB | 52.84B |
| Sectra AB | 51.79B |
| Camurus AB | 33.49B |
| Promimic AB | 204.04M |
| Xbrane Biopharma AB | 193.69M |
| Active Biotech AB | 174.24M |
| Diamyd Medical AB | 170.48M |